Hep Talk

Appointment Viewing Can videoconferencing improve outcomes for hep C patients who have used IV drugs? by Larry Buhl Thanks to a $7 million grant from the Patient-Centered...

Full Access Examining a legal victory for incarcerated Pennsylvanians with hep C by Larry Buhl With the advent of antiretroviral drugs, a cure for hepatitis C has...

Six drugs promise to further revolutionize HCV treatments by Larry Buhl The hepatitis C (HCV) treatment revolution is a little more than a year old, but...

LifeGuide Hep C is surpassing HIV as a deadlier disease by Larry Buhl There was a new milestone reached last month when a new study suggested...

HCV advocate, author & nurse Lucinda Porter offers perspectives on care by Larry Buhl Lucinda Porter, RN, understands viral hepatitis from both sides: as a healthcare practitioner and...

Last Straw New research shows snorting utensils carry a high risk of transmitting HCV by Larry Buhl The risk of contracting the hepatitis C virus (HCV) and...

Hep Talk Hepatitis C Antiviral Telaprevir Moves Closer to Approval by Larry Buhl Researchers in a recent Phase III study are encouraged by the results of a...

Hep Talk by Larry Buhl <strong>Warp Speeds <p> CROI researchers predict oral-only interferon-free treatment by 2014</strong><p> <a href="http://aumag.org/wordpress/wp-content/uploads/2013/06/warp_speed.jpg"><img src="http://aumag.org/wordpress/wp-content/uploads/2013/06/warp_speed.jpg" alt="warp_speed" width="600" height="450" class="alignleft size-full wp-image-7443" /></a><p> Advances leading...

Decisions, Decisions There are HCV treatment choices to make, but often few options by Larry Buhl If you’ve tested positive for the hepatitis C virus (HCV), there...

New meds offer hope for interferon-free regimen by Larry Buhl LifeGuide In the past year several protease inhibitors were introduced for chronic hepatitis C, marking a...